posner schlossman syndrome
Showing 1 - 2 of 2
Posner Schlossman Syndrome Trial in Beijing (FK-506 (Drug), Prednisolone Acetate 1% Oph Susp)
Recruiting
- Posner Schlossman Syndrome
- FK-506 (Drug)
- Prednisolone Acetate 1% Oph Susp
-
Beijing, Beijing, ChinaPeking University Third Hosipital
Aug 13, 2021
Posner Schlossman Syndrome Trial in Beijing
Recruiting
- Posner Schlossman Syndrome
-
Beijing, Beijing, ChinaPeking University Third Hosipital
Oct 11, 2020